- Erratum
- Open Access
- Published:
Erratum to: Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases
Biomaterials Research volume 21, Article number: 3 (2017)
Erratum
Following the publication of our article [1], we would like to make some corrections to the text as detailed below:
Patients and methods
This section includes the following text: “Due to the very small size of EVs (20-1000 nm) we had no fear of size related complications (i.e. engraftment syndrome associates MSCs transplantation) and intra-arterial EVs injection has been successfully used to reduce myocardial ischemia/reperfusion injury [18]. So, we’ve chosen the intra-arterial route to maximize EVs delivery to the kidneys.” We would like to clarify that Lai et al. [18] did not use intra-arterial injection of EVs, rather the MSC exosomes they injected reached the coronary arteries and successfully reduced myocardial IRI through arterial delivery of the MSC-EVs.
Ethical aspects
In this section “Amsterdam’s declarations” should read “Declaration of Helsinki”
Declarations
The Declaration section which reads:
“The study protocol has been approved by the health ethical committee of Sahel Teaching Hospital on April 2014. All patients have been informed verbally and a written consent for the research and publication has been signed prior any step according to Amsterdam’s declarations. No individual patient’s data were included. A written consent from both parents (for umbilical cord donors) has been obtained prior to any intervention.”
should read as follows:
“The study protocol has been approved by the health ethical committee of Sahel Teaching Hospital on April 2014. All patients have been informed verbally and written consent for participation in the research and for publication has been obtained prior to any step according to the Declaration of Helsinki. A written consent from both parents (for umbilical cord donors) has been obtained prior to any intervention.”
Reference
Nassar W, El-Ansary M, Sabry D, Mostafa MA, Fayad T, Kotb E, Temraz M, Saad A-N, Essa W, Adel H. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res. 2016;20:21.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s40824-016-0068-0.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Nassar, W., El-Ansary, M., Sabry, D. et al. Erratum to: Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 21, 3 (2017). https://doi.org/10.1186/s40824-017-0089-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40824-017-0089-3